Cramer: Buying Trea...
Amedisys Inc. (AMED: NASDAQ)
$10.56 -0.41 | -3.74%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 18.20 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 31.80 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 9.30 | 12.50 |
| Beta | 0.73 | 0.74 | 0.98 |
| Price to Sales (TTM) | 0.22 | 1.18 | 1.42 |
| Price to Book (MRQ) | 0.60 | 2.48 | 2.41 |
| Price to Tangible Book (MRQ) | 2.20 | -10.01 | 5.08 |
| Price to Cash Flow (TTM) | -0.90 | 11.60 | 9.80 |
| Price to Free Cash Flow (TTM) | -4.50 | -32.00 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.90 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 41.61 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 20.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 1.80 | 9.40 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -10.00 | 11.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 21.13 | 3.58 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -64.30 | -25.40 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -64.30 | -25.40 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | -3.65 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 10.47 | -2.53 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 0.80 | 1.40 | 1.10 |
| Current Ratio (MRQ) | 0.90 | 1.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.13 | 0.48 | 0.82 |
| Total Debt to Equity (MRQ) | 0.26 | 0.52 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.00 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 46.00 | 45.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 50.90 | 49.50 | 47.70 |
| EBITD Margin (TTM) | 15.50 | 14.20 | 18.90 |
| EBITD - 5 Yr Avg | 16.49 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -33.40 | 9.60 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 2.70 | 11.40 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.26 | 0.06 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 0.30 | 6.90 | 7.00 |
| Return on Assets (TTM) | -45.80 | 6.20 | 3.10 |
| Return on Assets - 5 Yr Avg | 0.40 | 7.90 | 2.50 |
| Return on Investment (TTM) | -65.00 | 8.10 | 7.90 |
| Return on Investment - 5 Yr Avg | 0.50 | 10.40 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 89,508.00 | 143,684.00 | 449,376.00 |
| Net Income/Employee (TTM) | -23,768.00 | 8,236.00 | 39,003.00 |
| Receivable Turnover (TTM) | 9.70 | 8.50 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 184.10 | 8.30 |
| Asset Turnover (TTM) | 1.40 | 1.20 | 0.40 |
Portfolios with AMED
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor13 Stocks the Debt Deal Cou...
- UserSole Holdings
- Contributor10 Best Stocks by Price-to-...
- Contributor10 Best Stocks by Price-to-...
- UserWatch
- UserSUPRATRADE STRONG BUY LIST ...
- UserPART 7 JPMorgan 28th Annual...
- UserFortune rs2009
Latest AMED Headlines from TheStreet
- Amedisys Stock Falls On Unusually High Volume (AMED) 05.09.12 | 01:05 pm
- Amedisys Stock Falls On Unusually High Volume (AMED) 02.28.12 | 04:02 pm
- 5 Dumbest Thanksgiving Quiz Answers 12.02.11 | 05:12 am
- The Five Dumbest Things on Wall Street Thanksgiving Quiz 11.24.11 | 05:11 am
- 3 New Investment Ideas From Greenlight's Einhorn 11.09.11 | 07:11 am
- Amedisys Inc. Stock Downgraded (AMED) 11.03.11 | 07:11 am
- Amedisys Stock Gaps Down On Today's Open (AMED) 11.01.11 | 09:11 am
- The 5 Dumbest Things on Wall Street: Oct. 7 10.07.11 | 07:10 am
- The 5 Dumbest Things on Wall Street: Week of October 2 - 7
10.07.11 | 05:10 am - Amedisys Stock Hits New 52-Week Low (AMED) 10.04.11 | 10:10 am
Press Releases for AMED
- Amedisys To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 05.30.12 | 07:05 am
- Amedisys Announces First Quarter Earnings Release And Conference Call Date - Business Wire 04.10.12 | 10:04 am
- Amedisys Scores 19% Above National Average On Treatment Goals Met At Home - Business Wire 03.15.12 | 07:03 am
- Amedisys To Present At The Raymond James 33rd Annual Institutional Investors Conference - Business Wire 03.02.12 | 10:03 am
- Amedisys Reports Fourth Quarter Financial Results; Issues 2012 Guidance - Business Wire 02.28.12 | 07:02 am
- Amedisys Increases Access For Managed Care Patients In The Southeast - Business Wire 02.27.12 | 07:02 am
- Amedisys Signs Managed Care Agreement With Blue Cross And Blue Shield Of Georgia - Business Wire 02.23.12 | 07:02 am
- Amedisys® Issues Heart Health Month Call-to-Action - Business Wire 02.14.12 | 07:02 am
- Amedisys Announces Fourth Quarter Earnings Release And Conference Call Date - Business Wire 01.31.12 | 11:01 am
- Julie Lewis, Vice President Of Health Policy For Amedisys Selected By Centers For Medicare And Medicaid Services For New Innovation Advisors Program To Improve Care For Patients - Business Wire 01.10.12 | 07:01 am
Partner Headlines for AMED
- Gentiva Modifies Credit Facility - Analyst Blog - Zacks 03.07.12 | 07:03 pm
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 02.24.12 | 01:02 am
- Gentiva to Pay Settlement Fee - Analyst Blog - Zacks 02.21.12 | 07:02 pm
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.24.12 | 09:01 am
- Oppenheimer Outperform on Amedisys - Benzinga 11.02.11 | 01:11 pm
- Can The Government Afford To Let Skilled Healthcare Prosper? - Seeking Alpha 11.02.11 | 08:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.05.11 | 09:10 am
- Healthcare Companies Are Gaming Medicare For Maximum Profits - Seeking Alpha 10.04.11 | 07:10 am
- 10 Recession Resistant Graham Picks - Seeking Alpha 10.02.11 | 08:10 am
- 4 Strong Cash-Flow Growth Stocks With Bullish Short Trends and Smart Money Buying Interest - Seeking Alpha 07.29.11 | 08:07 am





